Free Trial
Memorial Day Savings! Save $100 on MarketBeat All Access
Claim Your Discount
Claim MarketBeat All Access Sale Promotion

Skye Bioscience (SKYE) Institutional Ownership

Skye Bioscience logo
$0.73 -0.05 (-6.75%)
Closing price 05/19/2026 04:00 PM Eastern
Extended Trading
$0.74 +0.01 (+1.90%)
As of 05/19/2026 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Skye Bioscience (NASDAQ:SKYE)

Current
Institutional Ownership
Percentage
21.09%
Number of
Institutional Buyers
(last 12 months)
11
Total
Institutional Inflows
(last 12 months)
$1.31M
Number of
Institutional Sellers
(last 12 months)
7
Total
Institutional Outflows
(last 12 months)
$2.57M
Get SKYE Insider Trade Alerts

Want to know when executives and insiders are buying or selling Skye Bioscience stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

SKYE Institutional Buying and Selling by Quarter

Skye Bioscience Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/18/2026 XTX Topco Ltd53,040$40K0.0%N/A0.165%
2/18/2026 Millennium Management LLC380,478$285K0.0%-14.5%1.187%
2/17/2026 Schonfeld Strategic Advisors LLC93,407$70K0.0%-92.7%0.291%
11/17/2025 Qube Research & Technologies Ltd16,658$65K0.0%-68.1%0.052%
11/17/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.269,734$1.06M0.0%-7.0%0.841%
11/14/2025 Two Sigma Investments LP92,318$363K0.0%+46.2%0.288%
11/13/2025 Platinum Investment Management Ltd.233,095$916K0.1%-20.5%0.727%
11/12/2025 Dimensional Fund Advisors LP13,397$53K0.0%N/A0.043%
11/7/2025Vanguard Group Inc.882,785$3.47M0.0%+5.3%2.849%
10/21/2025 Capital Advisors Inc. OK10,000$39K0.0%N/A0.032%
8/15/2025 Tower Research Capital LLC TRC 10,927$46K0.0%+121.3%0.035%
8/14/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.289,979$1.21M0.0%-6.5%0.936%
8/14/2025 Qube Research & Technologies Ltd52,204$218K0.0%N/A0.168%
8/13/2025 Capital Advisors Wealth Management LLC50,800$212K0.0%+143.1%0.164%
8/13/2025 Marshall Wace LLP104,347$436K0.0%N/A0.337%
8/13/2025 Millington Financial Advisors LLC10,000$44K0.0%N/A0.032%
8/8/2025 Geode Capital Management LLC201,921$844K0.0%-54.2%0.652%
8/1/2025 Y Intercept Hong Kong Ltd10,046$42K0.0%N/A0.032%
6/27/2025 Goldman Sachs Group Inc.43,491$69K0.0%-38.8%0.140%
5/16/2025Goldman Sachs Group Inc.43,491$69K0.0%-38.8%0.140%
5/16/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.310,013$493K0.0%-5.0%1.001%
5/15/2025Driehaus Capital Management LLC620,395$986K0.0%-4.7%2.003%
5/13/2025Altium Capital Management LLC904,865$1.44M3.5%-20.6%2.921%
5/12/2025Nuveen LLC23,389$37K0.0%N/A0.076%
4/25/2025Capital Advisors Wealth Management LLC20,900$33K0.0%N/A0.067%
2/17/2025Squarepoint Ops LLC13,546$38K0.0%N/A0.045%
2/17/2025Two Sigma Advisers LP11,200$32K0.0%N/A0.037%
2/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.326,241$923K0.0%-5.3%1.075%
2/17/2025Ensign Peak Advisors Inc767,287$2.17M0.0%-14.7%2.529%
2/17/2025Deutsche Bank AG40,835$116K0.0%+365.0%0.135%
2/17/2025Bridgeway Capital Management LLC72,000$204K0.0%+26.3%0.237%
2/17/2025Braidwell LP825,732$2.34M0.1%N/A2.722%
2/17/2025Baker BROS. Advisors LP1,450,638$4.11M0.0%+1.1%4.781%
2/17/2025Bank of America Corp DE39,257$111K0.0%+37.4%0.129%
2/17/2025BNP Paribas Financial Markets31,637$90K0.0%-33.3%0.104%
2/17/2025Alyeska Investment Group L.P.456,163$1.29M0.0%-17.7%1.504%
2/14/2025Jane Street Group LLC36,057$102K0.0%+195.5%0.119%
2/14/2025Schonfeld Strategic Advisors LLC1,422,741$4.03M0.0%+48.3%4.689%
2/14/2025AdvisorShares Investments LLC88,391$250K0.0%-23.1%0.291%
2/14/2025Northern Trust Corp135,712$384K0.0%-3.7%0.447%
Your book attached (Ad)

Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.tc pixel

Download the Safe Trade Options Formula book for free before access closes
2/14/2025Altium Capital Management LLC1,139,000$3.22M0.9%-13.4%3.754%
2/13/2025Barclays PLC69,620$198K0.0%+20.3%0.229%
2/13/2025Wells Fargo & Company MN11,199$32K0.0%+49.0%0.037%
2/12/2025Geode Capital Management LLC405,694$1.15M0.0%+5.2%1.337%
2/11/2025Virtu Financial LLC10,142$29K0.0%N/A0.033%
2/11/2025Platinum Investment Management Ltd.434,046$1.23M0.1%-10.5%1.431%
2/6/2025Charles Schwab Investment Management Inc.62,363$176K0.0%+20.7%0.206%
1/1/2025JPMorgan Chase & Co.11,362$44K0.0%-24.1%0.037%
11/19/2024Barclays PLC57,889$226K0.0%+36.7%0.191%
11/16/2024Geode Capital Management LLC385,793$1.51M0.0%+4.2%1.272%
11/15/2024Barclays PLC57,889$226K0.0%+36.7%0.191%
11/15/2024Jane Street Group LLC12,200$48K0.0%N/A0.040%
11/15/2024Sphera Funds Management LTD.1,563,522$6.11M1.0%+20.4%5.153%
11/15/2024State Street Corp354,205$1.39M0.0%+7.0%1.167%
11/15/2024Point72 Asset Management L.P.416,424$1.63M0.0%-25.6%1.373%
11/15/2024Baker BROS. Advisors LP1,434,634$5.61M0.1%+186.9%4.729%
11/13/2024BNP Paribas Financial Markets47,417$185K0.0%+71.1%0.156%
9/16/2024Point72 DIFC Ltd6,000$48K0.0%N/A0.021%
9/16/2024Cubist Systematic Strategies LLC3,762$30K0.0%N/A0.013%
9/16/2024Point72 Asia Singapore Pte. Ltd.27,768$222K0.0%N/A0.099%
8/19/2024Point72 Asset Management L.P.560,000$4.49M0.0%N/A1.995%
8/16/2024Perceptive Advisors LLC500,000$4.01M0.1%N/A1.781%
8/16/2024Driehaus Capital Management LLC650,758$5.21M0.0%N/A2.319%
8/15/2024CVI Holdings LLC679,739$5.45M4.9%N/A2.422%
8/15/2024Point72 Asia Singapore Pte. Ltd.27,768$222K0.0%N/A0.099%
8/14/2024Cubist Systematic Strategies LLC3,762$30K0.0%N/A0.013%
8/14/2024Point72 DIFC Ltd6,000$48K0.0%N/A0.021%
8/14/2024Logos Global Management LP1,301,518$10.43M0.8%N/A4.637%
8/8/2024AdvisorShares Investments LLC26,000$210K0.0%N/A0.093%
8/1/2024Rhumbline Advisers19,754$158K0.0%N/A0.070%
7/26/2024Bank of New York Mellon Corp58,778$471K0.0%N/A0.209%


SKYE Institutional Ownership - Frequently Asked Questions

During the previous two years, 49 institutional investors and hedge funds held shares of Skye Bioscience. The most heavily invested institutionals were Logos Global Management LP ($10.43M), Sphera Funds Management LTD. ($6.11M), CVI Holdings LLC ($5.45M), Baker BROS. Advisors LP ($4.11M), Perceptive Advisors LLC ($4.01M), Vanguard Group Inc. ($3.47M), and Braidwell LP ($2.34M).Learn more on Skye Bioscience's institutional investors.

21.09% of Skye Bioscience's stock is owned by institutional investors. Learn more on SKYE's institutional investor holdings.

Of the 40 institutional investors that purchased Skye Bioscience's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Logos Global Management LP ($1.30M), Baker BROS. Advisors LP ($950.64K), Braidwell LP ($825.73K), CVI Holdings LLC ($679.74K), Driehaus Capital Management LLC ($650.76K), Point72 Asset Management L.P. ($560K), and Perceptive Advisors LLC ($500K).

Institutional investors have bought a total of 362,910 shares in the last 24 months. This purchase volume represents approximately $1.31M in transactions.

The following institutional investors have sold Skye Bioscience stock in the last 24 months: Schonfeld Strategic Advisors LLC ($1.19M), Geode Capital Management LLC ($238.87K), Millennium Management LLC ($64.40K), Platinum Investment Management Ltd. ($60.23K), MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. ($40.28K), Qube Research & Technologies Ltd ($35.55K), and Goldman Sachs Group Inc. ($27.59K).

Institutional investors have sold a total of 1,660,715 shares in the last 24 months. This volume of shares sold represents approximately $2.57M in transactions.



This page (NASDAQ:SKYE) was last updated on 5/20/2026 by MarketBeat.com Staff.
From Our Partners